Chen DS - Search Results

1

Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients.

Yuan Q, Song LW, Liu CJ, Li Z, Liu PG, Huang CH, Yan Y, Ge SX, Wang YB, Peng CY, Zhang J, Kao JH, Chen DS, Chen PJ, Xia NS. Yuan Q, et al. Among authors: chen ds, chen pj. Gut. 2013 Jan;62(1):182-4. doi: 10.1136/gutjnl-2012-302656. Epub 2012 Jun 14. Gut. 2013. PMID: 22698651 No abstract available.

2

Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis.

Liu CJ, Kao JH, Lai MY, Chen PJ, Chen DS. Liu CJ, et al. Among authors: chen ds, chen pj. J Med Virol. 2004 Apr;72(4):545-50. doi: 10.1002/jmv.20024. J Med Virol. 2004. PMID: 14981756

3

End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B.

Liu CJ, Huang WL, Chen PJ, Lai MY, Kao JH, Chen DS. Liu CJ, et al. Among authors: chen ds, chen pj. World J Gastroenterol. 2004 Dec 15;10(24):3574-8. doi: 10.3748/wjg.v10.i24.3574. World J Gastroenterol. 2004. PMID: 15534909 Free PMC article. Clinical Trial.

4

Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients.

Wang CC, Liu CJ, Lai MY, Kao JH, Chen DS. Wang CC, et al. Among authors: chen ds. Liver Int. 2007 Mar;27(2):235-9. doi: 10.1111/j.1478-3231.2006.01418.x. Liver Int. 2007. PMID: 17311619

5

IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients.

Hsu CS, Hsu SJ, Liu WL, Chen CL, Liu CJ, Chen PJ, Chen DS, Kao JH. Hsu CS, et al. Among authors: chen ds, chen cl, chen pj. Antivir Ther. 2013;18(4):599-606. doi: 10.3851/IMP2502. Epub 2013 Jan 7. Antivir Ther. 2013. PMID: 23296193

6

Peginterferon α in the treatment of chronic hepatitis B.

Tseng TC, Kao JH, Chen DS. Tseng TC, et al. Among authors: chen ds. Expert Opin Biol Ther. 2014 Jul;14(7):995-1006. doi: 10.1517/14712598.2014.907784. Epub 2014 Apr 16. Expert Opin Biol Ther. 2014. PMID: 24738850 Review.

7

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.

Liu CH, Liu CJ, Huang CF, Lin JW, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Lee CY, Chen SI, Yang SS, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Yu ML, Kao JH. Liu CH, et al. Among authors: chen ds, chen si, chen pj. Gut. 2015 Feb;64(2):303-11. doi: 10.1136/gutjnl-2014-307080. Epub 2014 Apr 19. Gut. 2015. PMID: 24747867 Clinical Trial.

8

Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers.

Tseng TC, Liu CJ, Yang HC, Chen CL, Yang WT, Tsai CS, Kuo SF, Verbree FC, Su TH, Wang CC, Liu CH, Chen PJ, Chen DS, Kao JH. Tseng TC, et al. Among authors: chen ds, chen cl, chen pj. Gut. 2015 Feb;64(2):292-302. doi: 10.1136/gutjnl-2014-306977. Epub 2014 Apr 24. Gut. 2015. PMID: 24763132

9

Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection.

Kao JH, Chen PJ, Lai MY, Chen DS. Kao JH, et al. Among authors: chen ds, chen pj. J Clin Microbiol. 2002 Apr;40(4):1207-9. doi: 10.1128/JCM.40.4.1207-1209.2002. J Clin Microbiol. 2002. PMID: 11923332 Free PMC article.

10

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B.

Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Lin CL, et al. Among authors: chen ds, chen pj. J Gastroenterol. 2002;37(4):283-7. doi: 10.1007/s005350200036. J Gastroenterol. 2002. PMID: 11993512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,033 results

Search Page